Provided by Tiger Trade Technology Pte. Ltd.

Mineralys Therapeutics, Inc.

23.63
-0.0900-0.38%
Post-market: 24.000.3700+1.57%19:41 EDT
Volume:928.30K
Turnover:22.06M
Market Cap:2.08B
PE:-5.40
High:24.34
Open:24.01
Low:23.55
Close:23.72
52wk High:47.65
52wk Low:22.30
Shares:88.16M
Float Shares:66.03M
Volume Ratio:0.56
T/O Rate:1.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.3763
EPS(LYR):-2.2900
ROE:-80.88%
ROA:-46.18%
PB:3.78
PE(LYR):-10.32

Loading ...

Mineralys Therapeutics CEO Jon Congleton Disposes of $1,909,665 Common Shares

Reuters
·
Yesterday

Mineralys Therapeutics to Present New Lorundrostat Launch-HTN Data at ASN Kidney Week 2026

Reuters
·
Yesterday

Mineralys to Present Lorundrostat Explore-OSA Hypertension Trial Data at AHA Hypertension Scientific Sessions 2026

Reuters
·
Oct 02

Mineralys Therapeutics Reports Inducement Awards Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Sep 30

Mineralys Director Brian Taylor Slingsby Disposes of 104,320 Common Shares for $3 Million

Reuters
·
Sep 25

Mineralys Therapeutics Joins Stifel Virtual Cardiometabolic Forum Fireside Chat

Reuters
·
Sep 25

Mineralys Says Transform-HTN Extension Data on Lorundrostat Set for Late-Breaking AHA 2026 Presentation

Reuters
·
Sep 24

Mineralys Therapeutics Chief Commercial Officer Eric Warren Disposes of Common Shares Worth USD 209,111.85

Reuters
·
Sep 23

Mineralys Therapeutics Reports Inducement Awards Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Sep 22

Mineralys Therapeutics Director Daphne Karydas Sells 3,000 Shares for $85,740

Reuters
·
Sep 18

Mineralys Therapeutics Grants Inducement Equity Awards Covering 52,080 Shares to New Hires

Reuters
·
Sep 10

Mineralys Therapeutics Reports Inducement Awards Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Sep 10

Mineralys Therapeutics Joins Wells Fargo Annual Healthcare Conference Fireside Chat

Reuters
·
Aug 26

Mineralys Chief Commercial Officer Eric Warren Disposes of 7,437 Common Shares Worth $193,226

Reuters
·
Aug 26

Why Mineralys Therapeutics (MLYS) Is Getting Fresh Attention

Simply Wall St.
·
Aug 23

Does New CMO Hire and Heavier Leverage Reshape the Bull Case For Mineralys Therapeutics (MLYS)?

Simply Wall St.
·
Aug 19

Mineralys Grants New CMO Inducement Awards for 135,000 Stock Options, 102,400 RSUs

Reuters
·
Aug 14

Mineralys Therapeutics Reports Inducement Award Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Aug 14

Analysts Offer Insights on Healthcare Companies: Monte Rosa Therapeutics (GLUE), Mineralys Therapeutics, Inc. (MLYS) and Adagene (ADAG)

TIPRANKS
·
Aug 13

Mineralys Therapeutics Confronts Heightened Refinancing and Liquidity Risks as 2031 Debt Maturity Looms

TIPRANKS
·
Aug 13